Biogen Inc.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spina…
Drug Manufacturers - General
US, Cambridge [HQ]
Lobbying Analysis
Lobbying · US Senate · InfluenceHistory
Download| FY | Quarter | Expense For Lobby Disclosure | LDA Reference |
|---|---|---|---|
| 2024 | 1 | $5,000,000 | LD-2 : 04/23/24 |
| 2024 | 1 | $5,000,000 | LD-2 : 04/17/24 |
| 2023 | 4 | $5,000,000 | LD-2 : 01/23/24 |
| 2023 | 4 | $5,000,000 | LD-2 : 01/23/24 |
| 2023 | 4 | $5,000,000 | LD-2 : 01/18/24 |
Get PRO Today
With PRO you will unlock 7 more lobbying disclosures for Biogen Inc.